Patents
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
07/2007
07/17/2007US7244708 Inhibitors of memapsin 2 and use thereof
07/17/2007US7244419 Gelling agent for oil
07/12/2007WO2007077508A2 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
07/12/2007WO2007029122A3 Fluorescein-based compounds and their use for peptide synthesis
07/12/2007WO2007008994A3 Glutamate aggrecanase inhibitors
07/12/2007WO2007002639A3 Non-nucleoside anti-hepacivirus agents and uses thereof
07/12/2007US20070161710 Bone targeting compounds for delivering agents to bone for interaction therewith
07/12/2007US20070161708 Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate
07/12/2007US20070161631 Substituted Phenoxyacetic Acids
07/12/2007US20070161574 Hcv ns-3 serine protease inhibitors
07/11/2007EP1806350A2 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
07/11/2007EP1806149A1 Solid medicinal preparation improved in solubility and stability and process for producing the same
07/11/2007EP1805134A2 4-aminotetracyclines and methods of use thereof
07/11/2007CN1997729A Surfactant composition method for production thereof and cosmetic comprising said composition
07/11/2007CN1997622A Polycationic compounds and uses thereof
07/11/2007CN1325468C Theanine extraction process
07/10/2007US7241810 For therapy of inflammatory, allergic and respiratory diseases
07/10/2007US7241802 Substituted cyclohexylcarboxylic acid amide compounds
07/10/2007CA2308850C Inhibitors of gap junction communication
07/05/2007WO2007076306A1 Fluorinated compounds
07/05/2007WO2007074789A1 1,3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof
07/05/2007US20070155990 Crystalline form of beta2 adrenergic receptor agonist
07/05/2007US20070155790 Meta-benzamidine derivatives as serine protease inhibitors
07/05/2007US20070155743 suchas N-(4(S)-amino-5(S)-hydroxy-2(S)-isopropyl-6-piperidin-1-ylhexyl)-2-(3-methoxypropoxy)benzamide dihydrochloride, used for the treatment of hypertension, cardiovasculr disorders, complications owing to diabetes, vision deffects, hyperaldosteronism, states of anxiety and cognitive disorders
07/05/2007US20070155708 e.g. 7-(4-fluorophenyl) sancycline; for treating tetracycline responsive states; antibiotic resistance; rickettsiae: pneumococci and Salmonella
07/05/2007US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction
07/05/2007CA2623250A1 Fluorinated compounds
07/04/2007CN1990461A Industrial preparation method for 3-amino-2, 2-dimethyl propionamide
07/04/2007CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
07/04/2007CN1989969A Cyclic protein tyrosine kinase inhibitors
06/2007
06/28/2007WO2007073202A1 Purification process of iodixanol
06/28/2007WO2007071626A2 Method for the production of aminoalkane acid amides
06/28/2007US20070149516 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide
06/28/2007US20070149488 Tetracycline Derivatives and Methods of Use Thereof
06/28/2007US20070148096 Contrast Agents
06/27/2007EP1799639A1 Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation
06/27/2007EP1799222A2 Compounds that inhibit replication of human immunodeficiency virus
06/27/2007EP1272459B1 7- and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
06/27/2007EP1144366B1 3,4-disubstituted acylanilide derivatives and their use as androgen receptor suppressors
06/27/2007CN1989100A Therapeutic compounds
06/27/2007CN1989099A Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases
06/27/2007CN1988914A Medical uses of intercellular communication facilitating compounds
06/21/2007US20070142663 T-butyl cascade polymers
06/21/2007US20070142476 Biphenyl-Derivatives as p38 Kinase Inhibitors
06/21/2007US20070142475 Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides and use as renin inhibitors
06/21/2007US20070142381 Calcium receptor modulating agents
06/21/2007US20070142338 Tetracycline Derivatives and Methods of Use Thereof
06/21/2007US20070142230 herbicides; act against broad-leaved weeds and grass weeds in crops such as wheat, rice, corn, soya and cotton without causing any significant damage to the crop plants
06/21/2007US20070141624 Activity-based probes and methods of their preparation ans use
06/20/2007EP1798241A1 Method of manufacturing a hapten between doxycycline and bovine serum albumin and application for detecting doxycycline in humans or animals
06/20/2007EP1798224A1 Biaryl derivative
06/20/2007EP1798219A1 Contrast agents
06/20/2007EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
06/20/2007CN1984883A Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
06/20/2007CN1984879A Carboxamido opioid compounds
06/20/2007CN1982289A Production of benzyl lidocaine halogenated amine
06/20/2007CN1982288A Production of benzobenzylamine acylamine
06/14/2007US20070135631 Heterocyclic cetp inhibitors
06/14/2007US20070135505 Aralkyl ester soft drugs
06/14/2007US20070135498 5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (1-hydroxymethyl-cyclopentyl)-amide; hypertension, atherosclerosis, unstable coronary syndrome, congestive heart failure, cardiac hypertrophy, cardiac fibrosis, cardiomyopathy postinfarction, alzheimers
06/14/2007US20070135497 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient
06/14/2007US20070135356 Gamma aminobutyric acid antagonist; naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative disorders; analgesics; drug withdrawal
06/14/2007US20070134729 Novel antibacterial agents
06/13/2007EP1795545A1 Novel polyacetylene derivatives
06/13/2007EP1214292B1 Tyrosine derivatives
06/13/2007CN1980892A Dpp-IV inhibitors
06/12/2007US7230134 By reacting aldehydes or ketones with ammonia or primary/secondary amines in presence of hydrogen-donor and homogeneous transition metal/complex catalysts
06/12/2007US7230133 For prophylaxis of of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis
06/12/2007US7230001 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof
06/07/2007WO2007064272A1 Benzhydryl amide derivatives as cannabinoid receptor antagonists or inverse agonists
06/07/2007WO2007064220A1 Purification of iodixanol
06/07/2007US20070129433 Diphenylamine derivatives
06/07/2007US20070129354 Biphenyl carboxylic amide p38 kinase inhibitors
06/07/2007US20070129347 Cyclohexylacetic acid compounds
06/07/2007US20070128120 Organic radiographic contrasting agents for medical devices
06/06/2007EP1792894A2 Contrast agents
06/06/2007EP1792624A1 Modified amino acids and compositions comprising them for delivering active agents
06/06/2007EP1791932A1 Alkylaminoacetamide lubricant additives
06/06/2007EP1791809A1 Substituted aniline derivatives
06/06/2007EP1483578A4 Artificial receptors, building blocks, and methods
06/06/2007DE102005059191A1 Procedure for the recovery of iopromide from iopromide mother liquor, useful for pharmaceutical purpose, comprises thermally treating the mother liquor in a reactor and subsequently crystallizing
06/06/2007CN1976892A Substituted enaminones, their derivatives and uses thereof
06/06/2007CN1319939C Process for preparing 3,4-dihydroxy-2-amino butyric acid derivatives
06/05/2007USRE39682 Enzyme inhibitors, for cancer therapy
06/05/2007US7227038 Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them
06/05/2007US7227036 Production process of aminomethyl group-containing benzamide compound
06/05/2007US7226578 Metal complexes that contain perfluoroalkyl, process for their production and their use in NMR diagnosis
05/2007
05/31/2007WO2007061036A1 Contrast medium using fullerene derivative
05/31/2007US20070123724 Method for preparing curable amide gellant compounds
05/31/2007US20070123723 Photoinitiator with phase change properties and gellant affinity
05/31/2007US20070123722 Curable amide gellant compounds
05/31/2007US20070123709 Beta-amino acids
05/31/2007US20070123592 Terephthalamide peptidomimetic compounds and methods
05/31/2007US20070123512 Propionamide derivatives useful as androgen receptor modulators
05/31/2007US20070123497 For parental administration
05/31/2007US20070123493 Benzamide derivative
05/30/2007EP1789380A1 Amino adamantane derivatives, methods for the production and use thereof
05/30/2007EP1177168B1 Caspase inhibitors and the use thereof
05/30/2007CN1972901A Method for producing (z)-1-phenyl-1-diethylaminocarbonyl-2-aminomethyl cyclopropane hydrochloride
05/30/2007CN1318023C Chemically-defined non-polymeric valency platform molecules and conjugates thereof
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 162